Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
Clin Pharmacol Ther. 2011 Jun;89(6):798-805. doi: 10.1038/clpt.2010.354. Epub 2011 Apr 6.
Transporter proteins mediate the cellular uptake and efflux of a broad variety of endogenous compounds, drugs, and their metabolites. Their systemic plasma concentrations are determined, in particular, by drug transporters expressed in the small intestine, liver, and kidney. In addition, drug transporters expressed in peripheral tissues (e.g., skeletal muscle) are likely to influence organ-specific drug concentrations and side effects. This review summarizes current findings regarding the association between adverse drug reactions in humans and modification of the functions of certain transporters caused by genetic factors or simultaneously administered inhibitors. We focus on adverse drug reactions occurring in humans due to transport in the small intestine, liver, kidneys, and blood-brain barrier.
转运蛋白介导广泛的内源性化合物、药物及其代谢物的细胞摄取和外排。它们的系统血浆浓度,特别是由小肠、肝脏和肾脏表达的药物转运蛋白决定。此外,在外周组织(如骨骼肌)表达的药物转运蛋白可能会影响器官特异性药物浓度和副作用。本综述总结了目前关于人类不良反应与遗传因素或同时给予的抑制剂引起的某些转运蛋白功能改变之间关联的研究结果。我们专注于由于在小肠、肝脏、肾脏和血脑屏障中的转运而在人类中发生的药物不良反应。